Nutriband Inc (NTRB)

Apr 30, 2025, 7:30 AM EDT - 4 weeks ago

Nutriband CEO Publishes Letter to Shareholders

NTRBW

Apr 11, 2025, 7:00 AM EDT - 7 weeks ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

NTRBW

Apr 4, 2025, 5:41 PM EDT - 2 months ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

NTRBW

Apr 4, 2025, 7:00 AM EDT - 2 months ago

Nutriband Signs Partnership Agreement with Charlotte FC

NTRBW

Feb 21, 2025, 7:00 AM EST - 3 months ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRBW

Feb 13, 2025, 7:00 AM EST - 3 months ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Feb 7, 2025, 8:45 AM EST - 4 months ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

NTRBW

Dec 31, 2024, 7:00 AM EST - 5 months ago

Nutriband Issues Letter to Shareholders

NTRBW

Dec 27, 2024, 9:25 AM EST - 5 months ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

NTRBW

Dec 4, 2024, 9:00 AM EST - 6 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Nov 27, 2024, 7:00 AM EST - 6 months ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

NTRBW

Oct 31, 2024, 8:35 AM EDT - 7 months ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

NTRBW

Oct 17, 2024, 7:00 AM EDT - 8 months ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

NTRBW

Oct 2, 2024, 7:00 AM EDT - 8 months ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

NTRBW

Sep 24, 2024, 7:00 AM EDT - 9 months ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

NTRBW

Sep 20, 2024, 6:50 AM EDT - 9 months ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

NTRBW

Sep 16, 2024, 4:00 PM EDT - 9 months ago

Nutriband Inc. Authorizes $1M Share Buyback Program

NTRBW

Sep 4, 2024, 7:00 AM EDT - 9 months ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Jul 19, 2024, 7:00 AM EDT - 11 months ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

NTRBW

Jul 15, 2024, 7:00 AM EDT - 11 months ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

NTRBW

Jun 20, 2024, 7:00 AM EDT - 1 year ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

NTRBW

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

NTRBW

May 16, 2024, 7:00 AM EDT - 1 year ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

NTRBW

May 10, 2024, 9:00 AM EDT - 1 year ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CANF

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

NTRBW

Apr 19, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Announces $8.4M Private Placement

NTRBW

Mar 25, 2024, 7:00 AM EDT - 1 year ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Mar 4, 2024, 7:00 AM EST - 1 year ago

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Jan 29, 2024, 7:00 AM EST - 1 year ago

Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st

NTRBW

Nov 28, 2023, 7:00 AM EST - 1 year ago

Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling

NTRBW

Nov 8, 2023, 7:00 AM EST - 1 year ago

Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape

NTRBW

Oct 11, 2023, 7:42 AM EDT - 1 year ago

Nutriband's Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm

NTRBW

Sep 20, 2023, 7:30 AM EDT - 1 year ago

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

NTRBW

Sep 12, 2023, 7:00 AM EDT - 1 year ago

Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023

Sep 11, 2023, 7:00 AM EDT - 1 year ago

Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

NTRBW

Aug 30, 2023, 8:00 AM EDT - 1 year ago

Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador

NTRBW

Jul 27, 2023, 8:30 AM EDT - 2 years ago

Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings

NTRBW

Jul 14, 2023, 9:20 AM EDT - 2 years ago

Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission

NTRBW

Jun 23, 2023, 7:00 AM EDT - 2 years ago

Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology

NTRBW

May 10, 2023, 8:00 AM EDT - 2 years ago

Nutriband to Attend 2023 BIO International Convention

NTRBW

Apr 27, 2023, 8:00 AM EDT - 2 years ago

Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023

NTRBW

Apr 19, 2023, 7:00 AM EDT - 2 years ago

Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023

NTRBW

Mar 28, 2023, 8:00 AM EDT - 2 years ago

Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology

NTRBW

Mar 8, 2023, 8:00 AM EST - 2 years ago

Nutriband Inc Joins Webull Corporate Communications Service Platform

NTRBW

Mar 2, 2023, 8:00 AM EST - 2 years ago

Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee

NTRBW

Feb 15, 2023, 6:00 AM EST - 2 years ago

Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register

NTRBW

Jan 24, 2023, 6:00 AM EST - 2 years ago

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference

NTRBW

Jan 5, 2023, 6:00 AM EST - 2 years ago

Nutriband Inc. Commences Trading on Upstream Under NTRB

NTRBW

Dec 30, 2022, 6:30 AM EST - 2 years ago

Nutriband Inc. Will Be the First Company to Dual List on Upstream

NTRBW

Dec 29, 2022, 6:30 AM EST - 2 years ago

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023

NTRBW